Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Video 1Video showing successful placement of 4 uncovered self-expanding metal stents in a stent-in-stent, Y-shaped configuration for cholangitis from plastic stents in a patient with unresectable cholangiocarcinoma.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755479 | PMC |
| http://dx.doi.org/10.1016/j.vgie.2021.09.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-Term Patency of Plastic Stents in Elderly Patients with Common Bile Duct Stones: A Prospective Pilot Study.
J Clin Med
August 2025
Department of Internal Medicine, Daegu Catholic University School of Medicine, Daegu 42472, Republic of Korea.
: Endoscopic retrograde cholangiopancreatography (ERCP) with stone extraction is the standard treatment for common bile duct (CBD) stones. However, when complete removal is not feasible, the temporary placement of a plastic stent (PS) is commonly used. This study aimed to assess 12-month stent patency in elderly patients with CBD stones.
View Article and Find Full Text PDFClinical Outcomes of Retained Plastic Biliary Stents: A Targeted Narrative Review.
Dig Dis Sci
August 2025
Interventional and Therapeutic Endoscopy, Hackensack University Medical Center, Hackensack, NJ, USA.
Plastic biliary stents (PBS) are commonly used for temporary drainage in both benign and malignant biliary conditions. Although intended for short-term use, they are often retained beyond the recommended interval, increasing the risk of complications such as stent occlusion, stentolith formation, cholangitis, biliary sepsis, and rarely, migration with perforation. PBS typically have a patency of approximately 3 months, after which the risk of occlusion and bacterial colonization increases substantially.
View Article and Find Full Text PDFIntegrating multi-omics in bile for biomarker discovery in cholangiocarcinoma.
Hepatol Commun
September 2025
Division of Gastroenterology and Hepatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
Background: Cholangiocarcinoma (CCA) is an aggressive cancer with a poor prognosis. Histopathology evaluation of brushings and biopsies obtained during endoscopic retrograde cholangiopancreatography (ERCP) currently remains the main method of diagnosis, which has limited sensitivity for malignancy detection. Our study aimed to identify human bile-derived biomarkers to improve CCA diagnosis.
View Article and Find Full Text PDFProspective evaluation study of a novel endoscopic revision technique after metal stent deployment for hepatic hilar obstruction.
Therap Adv Gastroenterol
July 2025
Second Department of Internal Medicine, Osaka Medical and Pharmaceutical University, Osaka, Japan.
Background: Malignant hilar biliary obstruction (MHBO) can be treated by stent deployment under endoscopic retrograde cholangiopancreatography. In case of unresectable MHBO, uncovered self-expandable metal stent (UCSEMS) deployment might be recommended. However, endoscopic revision is challenging.
View Article and Find Full Text PDFA 70-year-old male with lung cancer and interstitial pneumonia was diagnosed with ampullary carcinoma, causing obstructive jaundice. After the failure of endoscopic retrograde cholangiopancreatography, endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) was performed with a 7-Fr plastic stent (PS) into the B2 bile duct. Three months later, mild bleeding was observed during stent exchange, but was stopped by stent replacement.
View Article and Find Full Text PDF